PPD Australia Pty Ltd

Erwinase (crisantaspase) has been approved as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegylated asparaginase obtained from E. coli.

Nuceiva (prabotulinumtoxinA) is approved to treat glabellar lines.